Lycorine Regulate LXRα-Lipid Raft-TlLR4/NF-κB Signal Network to Inhibit Inflammation in Lung of Mice

Fuhan Wang,Qirui Zhang,Yanhe Zhang,Hongyuan Jing,Meng-yao Guo
DOI: https://doi.org/10.2139/ssrn.4052437
2022-01-01
Abstract:Lycorine is an alkaloid found in the bulb of the genus Lycoris in the Lycoris family. It has anti-inflammatory properties. The purpose of this study was to investigate the molecular mechanism of lycorine that can reduce acute lung injury(ALI). The model of ALI was induced by nasal injection of lipopolysaccharide(LPS) in mice. In vitro, A549 cells were stimulated with LPS and pretreated with lycorine. The results showed that lycorine reduced histopathological changes, myeloperoxidase (MPO) activity, and the production of inflammatory cytokines such as TNF-α, IL-1β, and IL-6 in mice with LPS-induced ALI. In vitro, lycorine dose-dependantly inhibited the production of TNF-α, IL-1β, and IL-6. It also inhibited transmission of TLR4/NF-κB passway in LPS-stimulated A549 cells. Lycorine increased cholesterol efflux through activation of LXRα-ABCA1/ABCG pathway. After Added LXRα inhibitor, the anti-inflammatory effect of lycorine eliminated. Conclusion: Lycorine can reduce ALI that induced by lipopolysaccharide. The anti-inflammatory mechanism of lycorine is related to up-regulation of the LXRα- ABCA1/ABCG pathway, which inhibits TLR4-mediated inflammation by reducing cholesterol and TLR4 transport to lipid rafts.
What problem does this paper attempt to address?